251 related articles for article (PubMed ID: 27343180)
21. Inhibition of Early Growth Response 1 in the Hippocampus Alleviates Neuropathology and Improves Cognition in an Alzheimer Model with Plaques and Tangles.
Qin X; Wang Y; Paudel HK
Am J Pathol; 2017 Aug; 187(8):1828-1847. PubMed ID: 28641077
[TBL] [Abstract][Full Text] [Related]
22. SEPT8 modulates β-amyloidogenic processing of APP by affecting the sorting and accumulation of BACE1.
Kurkinen KM; Marttinen M; Turner L; Natunen T; Mäkinen P; Haapalinna F; Sarajärvi T; Gabbouj S; Kurki M; Paananen J; Koivisto AM; Rauramaa T; Leinonen V; Tanila H; Soininen H; Lucas FR; Haapasalo A; Hiltunen M
J Cell Sci; 2016 Jun; 129(11):2224-38. PubMed ID: 27084579
[TBL] [Abstract][Full Text] [Related]
23. miR-124 Regulates the Expression of BACE1 in the Hippocampus Under Chronic Cerebral Hypoperfusion.
Zhang X; Huang X; Fang C; Li Q; Cui J; Sun J; Li L
Mol Neurobiol; 2017 May; 54(4):2498-2506. PubMed ID: 26984601
[TBL] [Abstract][Full Text] [Related]
24. Enhanced Expression of microRNA-1273g-3p Contributes to Alzheimer's Disease Pathogenesis by Regulating the Expression of Mitochondrial Genes.
Kim SH; Choi KY; Park Y; McLean C; Park J; Lee JH; Lee KH; Kim BC; Huh YH; Lee KH; Song WK
Cells; 2021 Oct; 10(10):. PubMed ID: 34685681
[TBL] [Abstract][Full Text] [Related]
25. MiR-16 attenuates β-amyloid-induced neurotoxicity through targeting β-site amyloid precursor protein-cleaving enzyme 1 in an Alzheimer's disease cell model.
Zhong Z; Yuan K; Tong X; Hu J; Song Z; Zhang G; Fang X; Zhang W
Neuroreport; 2018 Nov; 29(16):1365-1372. PubMed ID: 30142113
[TBL] [Abstract][Full Text] [Related]
26. Evidence for natural antisense transcript-mediated inhibition of microRNA function.
Faghihi MA; Zhang M; Huang J; Modarresi F; Van der Brug MP; Nalls MA; Cookson MR; St-Laurent G; Wahlestedt C
Genome Biol; 2010; 11(5):R56. PubMed ID: 20507594
[TBL] [Abstract][Full Text] [Related]
27. Epistasis between tau phosphorylation regulating genes (CDK5R1 and GSK-3beta) and Alzheimer's disease risk.
Mateo I; Vázquez-Higuera JL; Sánchez-Juan P; Rodríguez-Rodríguez E; Infante J; García-Gorostiaga I; Berciano J; Combarros O
Acta Neurol Scand; 2009 Aug; 120(2):130-3. PubMed ID: 19154537
[TBL] [Abstract][Full Text] [Related]
28. BACE1-AS prevents BACE1 mRNA degradation through the sequestration of BACE1-targeting miRNAs.
Zeng T; Ni H; Yu Y; Zhang M; Wu M; Wang Q; Wang L; Xu S; Xu Z; Xu C; Xiong J; Jiang J; Luo Y; Wang Y; Liu H
J Chem Neuroanat; 2019 Jul; 98():87-96. PubMed ID: 30959172
[TBL] [Abstract][Full Text] [Related]
29. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression.
Hébert SS; Horré K; Nicolaï L; Papadopoulou AS; Mandemakers W; Silahtaroglu AN; Kauppinen S; Delacourte A; De Strooper B
Proc Natl Acad Sci U S A; 2008 Apr; 105(17):6415-20. PubMed ID: 18434550
[TBL] [Abstract][Full Text] [Related]
30. The circular RNA ciRS-7 promotes APP and BACE1 degradation in an NF-κB-dependent manner.
Shi Z; Chen T; Yao Q; Zheng L; Zhang Z; Wang J; Hu Z; Cui H; Han Y; Han X; Zhang K; Hong W
FEBS J; 2017 Apr; 284(7):1096-1109. PubMed ID: 28296235
[TBL] [Abstract][Full Text] [Related]
31. Regulation of amyloid precursor protein (APP) phosphorylation and processing by p35/Cdk5 and p25/Cdk5.
Liu F; Su Y; Li B; Zhou Y; Ryder J; Gonzalez-DeWhitt P; May PC; Ni B
FEBS Lett; 2003 Jul; 547(1-3):193-6. PubMed ID: 12860412
[TBL] [Abstract][Full Text] [Related]
32. p35 and Rac1 underlie the neuroprotection and cognitive improvement induced by CDK5 silencing.
Posada-Duque RA; López-Tobón A; Piedrahita D; González-Billault C; Cardona-Gomez GP
J Neurochem; 2015 Jul; 134(2):354-70. PubMed ID: 25864429
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-650 Regulates the Pathogenesis of Alzheimer's Disease Through Targeting Cyclin-Dependent Kinase 5.
Lin L; Liu X; Cheng X; Li Y; Gearing M; Levey A; Huang X; Li Y; Jin P; Li X
Mol Neurobiol; 2023 May; 60(5):2426-2441. PubMed ID: 36656459
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1.
Boissonneault V; Plante I; Rivest S; Provost P
J Biol Chem; 2009 Jan; 284(4):1971-81. PubMed ID: 18986979
[TBL] [Abstract][Full Text] [Related]
35. A survey of Cdk5 activator p35 and p25 levels in Alzheimer's disease brains.
Tseng HC; Zhou Y; Shen Y; Tsai LH
FEBS Lett; 2002 Jul; 523(1-3):58-62. PubMed ID: 12123804
[TBL] [Abstract][Full Text] [Related]
36. Amyloid-β Fosters p35/CDK5 Signaling Contributing to Changes of Inhibitory Synapses in Early Stages of Cerebral Amyloidosis.
Kiss E; Groeneweg F; Gorgas K; Schlicksupp A; Kins S; Kirsch J; Kuhse J
J Alzheimers Dis; 2020; 74(4):1167-1187. PubMed ID: 32144981
[TBL] [Abstract][Full Text] [Related]
37. The long-non-coding RNA NEAT1 is a novel target for Alzheimer's disease progression via miR-124/BACE1 axis.
Zhao MY; Wang GQ; Wang NN; Yu QY; Liu RL; Shi WQ
Neurol Res; 2019 Jun; 41(6):489-497. PubMed ID: 31014193
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-26a/cyclin-dependent kinase 5 axis controls proliferation, apoptosis and in vivo tumor growth of diffuse large B-cell lymphoma cell lines.
Farina FM; Inguscio A; Kunderfranco P; Cortesi A; Elia L; Quintavalle M
Cell Death Dis; 2017 Jun; 8(6):e2890. PubMed ID: 28640256
[TBL] [Abstract][Full Text] [Related]
39. The amyloid precursor protein (APP) family members are key players in S-adenosylmethionine formation by MAT2A and modify BACE1 and PSEN1 gene expression-relevance for Alzheimer's disease.
Schrötter A; Pfeiffer K; El Magraoui F; Platta HW; Erdmann R; Meyer HE; Egensperger R; Marcus K; Müller T
Mol Cell Proteomics; 2012 Nov; 11(11):1274-88. PubMed ID: 22879628
[TBL] [Abstract][Full Text] [Related]
40. Glucose-induced expression of the cyclin-dependent protein kinase 5 activator p35 involved in Alzheimer's disease regulates insulin gene transcription in pancreatic beta-cells.
Ubeda M; Kemp DM; Habener JF
Endocrinology; 2004 Jun; 145(6):3023-31. PubMed ID: 14976144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
